rachelve wrote:I hope everyone had a wonderful holiday! I am sorry that I haven't updated my post in a while. I just wanted to post a quick update to let everyone know that my 6 month scans in early December showed that my target tumors had shrunk another 14% for a total shrinkage of 56% since I started the study in June!! In additional, most of my larger lung nodules are now below one centimeter in size, except for two that are just over one centimeter. Many other lung nodules have disappeared completely!! This is super exciting because I had dozens of lung nodules over a centimeter and 5-6 over two centimeters when I started the study last June (I also had one close to 3 centimeter that was scaring the death out of me!!). It is just so nice to have hope for the first time in a long time!!
In other good news, I was able to get another ASPS patient the information needed to get into the same study as me and he has been on the protocol nearly two months now and will get his first scans in the next week or two. The drug company is watching our progress with interest and Dr. Hong says that if he also responds, that the drug company has indicated that they will open up a treatment arm just for ASPS patients!!! This is super exciting as I get messages all the time from other ASPS patients wanting to get into the study, but it is currently closed to any new partipants. There are several other studies with MEDI4736, however, and this drug seems to be the common factor in the immunotherapy success stories thus far. Anyway, I get my next scans at the beginning of February, and will update you on my progress, but let me know if you have any questions in the meantime.
Take care,
Rachel
Hi Rachel,
I hope your early February scan will also be positive! And thanks for posting all this very useful information about your response to MEDI4736 and Mogamulizumab.
As we were discussing the possibility for my partner Elisa to get into a PD-1 or PD-L1 trial, such as MEDI4736, one point that was raised by her oncologist was whether your tumor had been tested for MSI (micro-satellite instability). There seems to be a correlation, at least in certain tumors, between PD-1/PD-L1 and MSI, and MSI-high is required to get into some of these trials. Elisa's tumor was tested, and the result came back as MSI-low. So, do you know if your tumor has been tested for MSI?
Again, I hope that you continue to respond to this combination!
Thanks and all the best,
Johannes